In patients with tumor-cell PD-L1 < 1%, median PFS was 3.2 months in NIVO + IPI versus 5.6 months in Chemo (HR 1.51 [95% CI 0.99–2.31]) (Online Resource 3). Here, CD274 is linked to neoplasm.